SCHEMBL1322704

SCHEMBL1322704

Cc1ccc(S(=O)(=O)N(C(C)O)C(C)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGER Q15109 1/20 0.52
MAPT P10636 2/20 0.50
MCOLN3 Q8TDD5 1/20 0.50
C5AR1 P21730 1/20 0.47
GAA P10253 2/20 0.46
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
POLB P06746 1/20 0.45
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
GLA P06280 1/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
CA3 P07451 1/20 0.43
CA6 P23280 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6487444 0.80 AGER (0.52) AGERMAPTMCOLN3C5AR1GAA
SCHEMBL14350865 0.79 PKM (0.52) GAAKEAP1NFE2L2CA1CA2
SCHEMBL3278846 0.78 AGER (0.53) AGERMAPTMCOLN3C5AR1GAA
SCHEMBL12180441 0.75 AGER (0.71) AGERMAPTMCOLN3C5AR1GAA
SCHEMBL1275171 0.74 SNCA (0.47) AGERMAPTGAACA12CA9
SCHEMBL28258824 0.74 AGER (0.50) AGERMAPTMCOLN3C5AR1GAA
SCHEMBL5909694 0.74 AGER (0.46) AGERMAPTMCOLN3C5AR1GAA
SCHEMBL9811625 0.74 MAPT (0.57) AGERMAPTMCOLN3C5AR1GAA
SCHEMBL30121315 0.74 GAA (0.54) AGERMAPTMCOLN3C5AR1GAA
SCHEMBL25678915 0.73 GAA (0.48) AGERMAPTMCOLN3GAACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058329-B2 as flameproofing agents for polymers such as polyesters, polyamides, polycarbonates, polystyrenes, polyethylene, polypropylene, phenolic and epoxy resins Schill+Seilacher “Struktol” Aktiengesellschaft (DE) 2011-11-15 US claimed
EP-1866320-B1 NITROGEN-CONTAINING BRIDGED DERIVATIVES OF 6H-DIBENZ(E,E)(1,2)-OXAPHOSPHORINE-6-OXIDES METHOD FOR PRODUCTION AND USE THEREOF AS FLAME-RETARDANT AGENTS SCHILL & SEILACHER STRUKTOL AG (DE) 2009-02-18 EP claimed
US-20080167405-A1 Nitrous Bridged Derivatives of 6H-Dibenz[C,E][1,2]-Oxaphosphorine-6-Oxides, Process For the Preparation and Use Thereof SCHILL+SEILACHER "STRUKTOL" AKTIENGESELLSCHAFT (DE) 2008-07-10 US claimed
EP-0325762-B1 Macrocyclic chelating agents and chelates thereof BRACCO SPA (IT) 1995-03-22 EP claimed
EP-0325762-B1 Macrocyclic chelating agents and chelates thereof BRACCO SPA (IT) 1995-03-22 EP disclosed
US-5132409-A Derivatives of 1,4,7,10-Tetraazacyclododecane BRACCO INDUSTRIA CHIMICA S.P.A. (IT) 1992-07-21 US disclosed
EP-0325762-A1 Macrocyclic chelating agents and chelates thereof BRACCO S.p.A. (IT) 1989-08-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167405-A1 Nitrous Bridged Derivatives of 6H-Dibenz[C,E][1,2]-Oxaphosphorine-6-Oxides, Process For the Preparation and Use Thereof PFAS, PCBP1, DNPH1 AGER 4109/4885MAPT 3116/4885MCOLN3 4535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.